Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma

Cancer Letters

Volumn 250, Issue 2, 2007, Pages 237-249

  Ho, Ming Chih ^a,b   Chen, Chiung Nien ^a,b,c   Lee, Hsinyu ^b   Hsieh, Fon Jou ^b   Shun, Chia Tung ^a   Chang, Chi Lun ^b   Lai, Yeun Tyng ^a,b   Lee, Po Huang ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c RESEARCH CENTER FOR APPLIED SCIENCES   (Taiwan)

Author keywords

Angiogenesis; Hepatocellular carcinoma; Placenta growth factor; Recurrence; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; VASCULOTROPIN A; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; EVALUATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; DNA PRIMERS; HUMANS; LIVER NEOPLASMS; PREGNANCY PROTEINS; PROGNOSIS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 34047159945     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.10.005     Document Type: Article

References (36)

1. Yamaguchi R., Yano H., Lemura A., Ogasawara S., Haramaki M., and Kojiro M. Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology 28 (1998) 68-77
2. Poon R.T., Fan S.T., and Wong J. Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann. Surg. 232 (2000) 10-24
3. Ng I.O., Poon R.T., Lee J.M., Fan S.T., Ng M., and Tso W.K. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am. J. Clin. Pathol. 116 (2001) 838-845
4. Sun H.C., and Tang Z.Y. Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives. J. Cancer Res. Clin. Oncol. 130 (2004) 307-319
5. Miyata Y., Kanda S., Ohba K., Nomata K., Hayashida Y., Eguchi J., Hayashi T., and Kanetake H. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D. Clin. Cancer Res. 12 (2006) 800-806
6. Soumaoro L.T., Uetake H., Takagi Y., Lida S., Higuchi T., Yasuno M., Enomoto M., and Sugihara K. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis. Dis. Colon Rectum. 49 (2006) 392-398
7. Cao Y., Linden P., Farnebo J., Cao R., Eriksson A., Kumar V., Qi J.H., Claesson-Welsh L., and Alitalo K. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA 95 (1998) 14389-14394
8. Yamaguchi R., Yano H., Nakashima O., Akiba J., Nishida N., Kurogi M., and Kojiro M. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma. J. Gastroenterol. Hepatol. 21 (2006) 152-160
9. Li X.M., Tang Z.Y., Zhou G., Liu Y.K., and Ye S.L. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 17 (1998) 13-17
10. Failla C.M., Odorisio T., Cianfarani F., Schietroma C., Puddu P., and Zambruno G. Placenta growth factor is induced in human keratinocytes during wound healing. J. Invest. Dermatol. 115 (2000) 388-395
11. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nature Med. 389 (2000) 389-395
12. Cao Y., Ji W.R., Qi P., Pang Q., Rosin A., and Cao Y. Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem. Biophys. Res. Commun. 235 (1997) 493-498
13. Chen C.N., Hsieh F.J., Cheng Y.M., Cheng W.F., Su Y.N., Chang K.J., and Lee P.H. The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer. Cancer Lett. 213 (2004) 73-82
14. Matsumoto K., Suzuki K., Koike H., Okamura K., Tsuchiya K., Uchida T., Takezawa Y., Kobayashi M., and Yamanaka H. Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels. Anticancer Res. 23 (2003) 4953-4958
15. Lacal P.M., Failla C.M., Pagani E., Odorisio T., Schietroma C., Falcinelli S., Zambruno G., and D'Atri S. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J. Invest. Dermatol. 115 (2000) 1000-1007
16. Wei S.C., Tsao P.N., Yu S.C., Shun C.T., Tsai-Wu J.J., Wu C.H., Su Y.N., Hsieh F.J., and Wong J.M. Placenta growth factor expression is correlated with survival of patients with colorectal cancer. Gut 54 (2005) 666-672
17. Hu R.H., Lee P.H., Yu S.C., Dai H.C., Sheu J.C., Lai M.Y., Hsu H.C., and Chen D.S. Surgical resection of recurrent hepatocellular carcinoma: prognosis and analysis of risk factors. Surgery 120 (1996) 23-29
18. Poon R.T., Fan S.T., Ng I.O., Lo C.M., Liu C.L., and Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89 (2000) 500-507
19. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumour angiogenesis and metastasis: correlation in invasive breast cancer. N. Engl. J. Med. 324 (1991) 1-8
20. Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., Wu Y., Bono F., Devy L., Beck H., Scholz D., Acker T., DiPalma T., Dewerchin M., Noel A., Stalmans I., Barra A., Blacher S., Vandendriessche T., Ponten A., Eriksson U., Plate K.H., Foidart J.M., Schaper W., Charnock-Jones D.S., Hicklin D.J., Herbert J.M., Collen D., and Persico M.G. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7 (2001) 575-583
21. Larcher F., Franco M., Bolontrade M., Rodriguez-Puebla M., Casanova L., Navarro M., Yancopoulos G., Jorcano J.L., and Conti C.J. Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis. Mol. Carcinogen. 37 (2003) 83-90
22. Luttun A., Tjwa M., and Carmeliet P. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. Ann. N.Y. Acad. Sci. 979 (2002) 80-93
23. Bae D.G., Kim T.D., Li G., Yoon W.H., and Chae C.B. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis. Clin. Cancer Res. 11 (2005) 2651-2661
24. Kimura H., Nakajima T., Kagawa K., Deguchi T., Kakusui M., Katagishi T., Okanoue T., Kashima K., and Ashihara T. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. Liver 18 (1998) 14-19
25. Shi M., Zhang C.Q., Zhang Y.Q., Liang X.M., and Li J.Q. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J. Surg. 28 (2004) 376-381
26. Poon R.T., Ng I.O., Lau C., Yu W.C., Yang Z.F., Fan S.T., and Wong J. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J. Clin. Oncol. 20 (2002) 1775-1785
27. Bussolati B., Dunk C., Grohman M., Kontos C.D., Mason J., and Ahmed A. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am. J. Pathol. 159 (2001) 993-1008
28. Taylor A.P., Rodriguez M., Adams K., Goldenberg D.M., and Blumenthal R.D. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence. Int. J. Cancer 105 (2003) 158-164
29. Zhao B., Cai J., and Boulton M. Expression of placenta growth factor is regulated by both VEGF and hyperglycaemia via VEGFR-2. Microvasc. Res. 68 (2004) 239-246
30. Batra S., Perelman N., Luck L.R., Shimada H., and Malik P. Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab. Invest. 83 (2003) 1477-1487
31. Autiero M., Waltenberger J., Communi D., Kroll J., Plaisance S., De Mo M., Bono F., Kliche S., Fellbrich G., Ballmer-Hofer K., Maglione D., Mayr-Beyrle U., Dewerchin M., Dombrowski S., Stanimirovic D., Van Hummelen P., Dehio C., Hicklin D.J., Persico G., Herbert J.M., Communi D., Shibuya M., Collen D., Conway E.M., and Carmeliet P. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat. Med. 9 (2003) 936-943
32. Wada H., Nagano H., Yamamoto H., Yang Y., Kondo M., Ota H., Nakamura M., Yoshioka S., Kato H., Damdinsuren B., Tang D., Marubashi S., Miyamoto A., Takeda Y., Umeshita K., Nakamori S., Sakon M., Dono K., Wakasa K., and Monden M. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha. Liver Int. 26 (2006) 414-423
33. Amaoka N., Saio M., Nonaka K., Imai H., Tomita H., Sakashita F., Takahashi T., Sugiyama Y., Takami T., and Adachi Y. Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma. Oncol. Rep. 16 (2006) 3-10
34. El-Assal O.N., Yamanoi A., Soda Y., Yamaguchi M., Igarashi M., Yamamoto A., Nabika T., and Nagasue N. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 27 (1998) 1554-1562
35. Parr C., Watkins G., Boulton M., Cai J., and Jiang W.G. Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur. J. Cancer. 41 (2005) 2819-2827
36. Autiero M., Luttun A., Tjwa M., and Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J. Thromb. Haemost. 1 (2003) 1356-1370